[HTML][HTML] Vitamin D and autoimmune rheumatic diseases

L Athanassiou, I Kostoglou-Athanassiou, M Koutsilieris… - Biomolecules, 2023 - mdpi.com
Vitamin D is a steroid hormone with potent immune-modulating properties. It has been
shown to stimulate innate immunity and induce immune tolerance. Extensive research …

T cell abnormalities in systemic sclerosis

W Jin, Y Zheng, P Zhu - Autoimmunity Reviews, 2022 - Elsevier
Systemic sclerosis (SSc) is an autoimmune disease with a poor prognosis. To date, the
pathogenesis of SSc is still unclear; moreover, its pathological conditions include …

T follicular helper cells in autoimmune diseases

X Wei, X Niu - Journal of Autoimmunity, 2023 - Elsevier
T follicular helper (Tfh) cells with the phenotype of mainly expressing surface molecules
CXC motif chemokine receptor type 5 (CXCR5), inducible co-stimulator (ICOS), secreting …

Clinical treatment options in scleroderma: recommendations and comprehensive review

M Zhao, J Wu, H Wu, AH Sawalha, Q Lu - Clinical Reviews in Allergy & …, 2022 - Springer
There are two major clinical subsets of scleroderma:(i) systemic sclerosis (SSc) is a complex
systemic autoimmune disorder characterized by inflammation, vasculopathy, and excessive …

Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review

S McGaugh, P Kallis, A De Benedetto… - Dermatologic …, 2022 - Wiley Online Library
Morphea and systemic sclerosis (SSc) are rare disorders of connective tissue characterized
by increased skin thickness and fibrosis, with current treatment options having variable …

[HTML][HTML] Calcinosis cutis and calciphylaxis in autoimmune connective tissue diseases

I Mormile, F Mosella, P Turco, F Napolitano… - Vaccines, 2023 - mdpi.com
Calcinosis represents a severe complication of several autoimmune disorders. Soft-tissue
calcifications have been classified into five major types: dystrophic, metastatic, idiopathic …

Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features

C Corallo, A Fioravanti, S Tenti, G Pecetti… - Rheumatology …, 2019 - Springer
We evaluated the presence of sarcopenia in a population of systemic sclerosis (SSc)
patients, with respect to nutritional, clinical, and laboratory features. A total of 62 patients …

Mesenchymal stem cell-derived exosomes ameliorate dermal fibrosis in a murine model of bleomycin-induced scleroderma

M Li, HP Zhang, XY Wang, ZG Chen… - Stem Cells and …, 2021 - liebertpub.com
Mesenchymal stem cells (MSCs) have become a promising therapeutic strategy for
scleroderma. Exosomes derived from MSCs (MSC-exosomes) possess functional properties …

[HTML][HTML] Fat grafting subjectively improves facial skin elasticity and hand function of scleroderma patients

AL Strong, W Adidharma, OH Brown… - … Surgery–Global Open, 2021 - journals.lww.com
Systemic scleroderma is a chronic connective tissue disease characterized by internal organ
and skin fibrosis. Unfortunately, there is a lack of efficacious treatments for cutaneous …

GRB2 serves as a viable target against skin fibrosis in systemic sclerosis by regulating endothelial cell apoptosis

Y Huang, H Zhao, X Shi, J Liu, JM Lin, Q Ma… - Journal of …, 2023 - Elsevier
Abstract Background Systemic Sclerosis (SSc) is an autoimmune disease characterized by
vascular and immune system dysfunction, along with tissue fibrosis. Our previous study …